Research & Discovery
The latest research news in genetics and genomics.
Quanterix Projects Q4 2021 Revenues of $29M to $31M
The company projected full year 2021 revenues of $109 million to $111 million, up from $86.4 million in 2020.
MeMed Closes $93M Private Financing Round
The company said it will use the funds to scale manufacturing and accelerate commercialization of its MeMed BV and MeMed COVID-19 Severity tests.
Aspira Women's Health Preliminary Q4 OVA1 Sales up 23 Percent; Firm Details Pipeline Progess
The company also announced a five-year deal with healthcare group Axia Women's Health to provide in-house genetic carrier screening.
Nucleix Raises Additional $22M
The Israeli molecular diagnostics firm is developing liquid biopsy tests for early-stage and recurring cancer detection based on methylation patterns.
Proteomics Goes Public in 2021
Premium
Seven proteomics firms, ranging from tools companies to diagnostics outfits, listed on public markets in 2021 in a sign of growing interest in the space.
Nov 10, 2021
Aspira Women's Health Q3 Revenues Up 34 Percent
Nov 9, 2021